{"id":"W7023538373","doi":"","title":"Pharmacy Choice - Pharmaceutical News - Enanta Pharmaceuticals Reports Financial Results for its Fiscal Second Quarter Ended March 31, 2014","year":2014,"lang":"en","type":"other","venue":"","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"","keywords":"Quarter (Canadian coin); Pharmacy; Fiscal year; Community pharmacy; Revenue","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002838625,0.0008115724,0.0009161993,0.003312092,0.002039652,0.008912323,0.001341334,0.003917994,0.3477885],"category_scores_gemma":[0.01333714,0.0005065642,0.0006027349,0.003215204,0.0006997885,0.002195681,0.00180166,0.00377651,0.1691414],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.005644616,"about_ca_system_score_gemma":0.008758013,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.03461775,"about_ca_topic_score_gemma":0.0591625,"domain_scores_codex":[0.9974174,0.0001828896,0.00007977405,0.0001912328,0.001731061,0.0003974979],"domain_scores_gemma":[0.9934297,0.001251572,0.0005523046,0.0004226831,0.002646356,0.001697311],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001936954,0.0000947451,0.0005202046,0.00005110798,0.000008291457,0.00002432318,0.00001094658,0.0001116935,0.00005662125,0.003547068,0.9857103,0.009670994],"study_design_scores_gemma":[0.0001491192,0.00006884167,0.00853023,0.0001056673,0.00001255228,0.00002876044,0.00008058399,0.0008022253,0.0007481257,0.00290312,0.9865415,0.00002925498],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"other","genre_gemma":"other","genre_scores_codex":[0.003652652,0.001743782,0.0006251149,0.02067483,0.00384793,0.0003145885,0.1145312,0.001342848,0.853267],"genre_scores_gemma":[0.008928442,0.0007083564,0.0003499349,0.00184985,0.001014629,0.00010856,0.01914027,0.0003730888,0.9675269],"genre_candidate":"other","genre_consensus":"other","teacher_disagreement_score":0.3477885,"threshold_uncertainty_score":0.9303005,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08429951513084548,"score_gpt":0.3551227256445844,"score_spread":0.2708232105137389,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}